search icon
irwd-img

Ironwood Pharmaceuticals Inc Share Price

IRWD
NSQ
$4.56
+$0.11
(2.47%)
1D
Industry: Biotechnology Sector: Health Care

Ironwood Pharmaceuticals Inc Analyst Forecast

Ironwood Pharmaceuticals Inc Share Price Chart

Ironwood Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$723.92M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
24.7222
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.98M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.53 L
$5.78 H
$4.56

About Ironwood Pharmaceuticals Inc, Common Stock

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 for short bowel syndrome patients dependent on parenteral support, as well as for acute graft versus host disease. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Ironwood Pharmaceuticals Inc Stock Returns

Time FrameIRWDSectorS&P500
1-Week Return-6.75%0.06%-2.06%
1-Month Return6.05%-2.06%-2.06%
3-Month Return122.44%6.1%1.11%
6-Month Return466.46%18.64%7.13%
1-Year Return135.05%5.25%11.74%
3-Year Return-60.31%17.35%65.43%
5-Year Return-57.22%33.7%73.53%
10-Year Return-30.15%143.77%266.66%

Ironwood Pharmaceuticals Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue389.52M413.75M410.60M442.74M351.41M[{"date":"2020-12-31","value":87.98,"profit":true},{"date":"2021-12-31","value":93.45,"profit":true},{"date":"2022-12-31","value":92.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":79.37,"profit":true}]
Cost of Revenue3.14M70.41M1.42M6.15M7.55M[{"date":"2020-12-31","value":4.45,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":2.01,"profit":true},{"date":"2023-12-31","value":8.73,"profit":true},{"date":"2024-12-31","value":10.73,"profit":true}]
Gross Profit386.39M343.35M409.18M436.59M343.86M[{"date":"2020-12-31","value":88.5,"profit":true},{"date":"2021-12-31","value":78.64,"profit":true},{"date":"2022-12-31","value":93.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.76,"profit":true}]
Gross Margin99.19%82.98%99.65%98.61%97.85%[{"date":"2020-12-31","value":99.54,"profit":true},{"date":"2021-12-31","value":83.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.95,"profit":true},{"date":"2024-12-31","value":98.19,"profit":true}]
Operating Expenses243.45M111.09M158.84M1.38B250.73M[{"date":"2020-12-31","value":17.62,"profit":true},{"date":"2021-12-31","value":8.04,"profit":true},{"date":"2022-12-31","value":11.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":18.14,"profit":true}]
Operating Income142.94M232.26M250.34M(945.43M)93.12M[{"date":"2020-12-31","value":57.1,"profit":true},{"date":"2021-12-31","value":92.78,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-377.66,"profit":false},{"date":"2024-12-31","value":37.2,"profit":true}]
Total Non-Operating Income/Expense(62.05M)(62.03M)3.99M5.85M(56.49M)[{"date":"2020-12-31","value":-1060.37,"profit":false},{"date":"2021-12-31","value":-1059.91,"profit":false},{"date":"2022-12-31","value":68.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-965.35,"profit":false}]
Pre-Tax Income108.86M200.66M252.42M(948.07M)65.20M[{"date":"2020-12-31","value":43.13,"profit":true},{"date":"2021-12-31","value":79.49,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-375.59,"profit":false},{"date":"2024-12-31","value":25.83,"profit":true}]
Income Taxes2.69M(327.79M)77.36M83.49M64.32M[{"date":"2020-12-31","value":3.22,"profit":true},{"date":"2021-12-31","value":-392.61,"profit":false},{"date":"2022-12-31","value":92.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":77.04,"profit":true}]
Income After Taxes106.18M528.45M175.06M(1.03B)880.00K[{"date":"2020-12-31","value":20.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.13,"profit":true},{"date":"2023-12-31","value":-195.21,"profit":false},{"date":"2024-12-31","value":0.17,"profit":true}]
Income From Continuous Operations106.18M528.45M175.06M(980.95M)880.00K[{"date":"2020-12-31","value":20.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.13,"profit":true},{"date":"2023-12-31","value":-185.63,"profit":false},{"date":"2024-12-31","value":0.17,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income106.18M528.45M175.06M(1.00B)880.00K[{"date":"2020-12-31","value":20.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.13,"profit":true},{"date":"2023-12-31","value":-189.66,"profit":false},{"date":"2024-12-31","value":0.17,"profit":true}]
EPS (Diluted)0.791.180.970.640.01[{"date":"2020-12-31","value":66.95,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.2,"profit":true},{"date":"2023-12-31","value":54.24,"profit":true},{"date":"2024-12-31","value":1.24,"profit":true}]

Ironwood Pharmaceuticals Inc Ratios

Ironwood Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

IRWD
Cash Ratio 0.58
Current Ratio 1.13

Ironwood Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IRWD
ROA (LTM) 22.88%
ROE (LTM) -574.72%

Ironwood Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IRWD
Debt Ratio Lower is generally better. Negative is bad. 1.67
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.67

Ironwood Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IRWD
Trailing PE 24.72
Forward PE 12.33
P/S (TTM) 2.14
P/B 2.59
Price/FCF 15
EV/R 3.50
EV/Ebitda 9.18
PEG NM

FAQs

What is Ironwood Pharmaceuticals Inc share price today?

Ironwood Pharmaceuticals Inc (IRWD) share price today is $4.56

Can Indians buy Ironwood Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Ironwood Pharmaceuticals Inc (IRWD) on Vested. To buy from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IRWD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ironwood Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Ironwood Pharmaceuticals Inc (IRWD) via the Vested app. You can start investing in Ironwood Pharmaceuticals Inc (IRWD) with a minimum investment of $1.

How to invest in Ironwood Pharmaceuticals Inc shares from India?

You can invest in shares of Ironwood Pharmaceuticals Inc (IRWD) via Vested in three simple steps:

  • Click on Sign Up or Invest in IRWD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ironwood Pharmaceuticals Inc shares
What is Ironwood Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Ironwood Pharmaceuticals Inc (IRWD) is $5.78. The 52-week low price of Ironwood Pharmaceuticals Inc (IRWD) is $0.53.

What is Ironwood Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ironwood Pharmaceuticals Inc (IRWD) is 24.7222

What is Ironwood Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ironwood Pharmaceuticals Inc (IRWD) is 2.59

What is Ironwood Pharmaceuticals Inc dividend yield?

The dividend yield of Ironwood Pharmaceuticals Inc (IRWD) is 0.00%

What is the Market Cap of Ironwood Pharmaceuticals Inc?

The market capitalization of Ironwood Pharmaceuticals Inc (IRWD) is $723.92M

What is Ironwood Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Ironwood Pharmaceuticals Inc is IRWD

How Can Investors Use Ironwood Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Ironwood Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Ironwood Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Ironwood Pharmaceuticals Inc shares for Indian investors?

When investing in Ironwood Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Ironwood Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Ironwood Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Ironwood Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Ironwood Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top